US › Healthcare

Armata Pharmaceuticals Inc (ARMP)

US · Healthcare · Biotechnology

$3.37+9.06%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$2.5M

Revenue YoY

+15.7%

Net profit

$74.1M

EPS

$-0.27

EPS estimate

$-0.48

Net margin

2,953.8%

EPS came in at -0.27 against a street estimate of -0.48 — a beat of 43.7%.

Key statistics

Market cap

$114.9M

Forward P/E

0.0

P/B

2.11

Book value

$-6.22

EPS (TTM)

$-5.27

52-week high

$16.34

52-week low

$2.75

50-day MA

$4.46

200-day MA

$7.19

Beta

1.41

Analyst view

Analysts rate Armata Pharmaceuticals Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $17.50.

Shareholding

Insiders

67.64%

Institutions

13.46%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Armata Pharmaceuticals Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.